In this report, we describe the utilization of various medical products during pregnancies ending in live-birth delivery where the mother is linked to a singleton infant in the Sentinel Common Data Model (SCDM) Mother‐Infant Linkage (MIL) table. Medical products of interest (MOIs) include those with pregnancy‐related postmarketing requirements (PMRs) and/or postmarketing commitments (PMCs), those involved in pregnancy registries, or those investigated in studies listed in ClinicalTrials.gov that fulfilled the following search criteria elements with respect to their use during pregnancy: 1) Pregnant, Pregnancy, Observational, 2) Limited to studies associated with a drug or biologic.
We distributed this request to four Sentinel Data Partners on March 24, 2023. The study period includes data from January 1, 2008 to June 30, 2022.
A companion analysis describes utilization of various medical products during pregnancies ending in live-birth delivery but does not utilize the Mother‐Infant Linkage (MIL) table.